Suchergebnisse - "Quinn, David I"

PubPharm (357)

1

Three- and Seven-month Prostate-specific Antigen Levels as Prognostic Markers for Overall Survival in Metastatic Hormone-sensitive Prostate Cancer : Results from SWOG S1216, a Phase 3 Randomized Trial of Androgen Deprivation Plus Orteronel or Bicalutamide

enthalten in: European urology oncology | 2024

von Parikh, M. | Tangen, C. | Hussain, M. | +19

2

Markers of bone metabolism and overall survival in men with bone-metastatic hormone sensitive prostate cancer (HSPC) : A subset analysis of SWOG S1216, a phase III trial of androgen deprivation with or without orteronel

enthalten in: Prostate cancer and prostatic diseases | 2024

von Lara, P. | Mayerson, E. | Gertz, E. | +12

3

Bone Biomarkers and Subsequent Survival in Men with Hormone-sensitive Prostate Cancer : Results from the SWOG S1216 Phase 3 Trial of Androgen Deprivation Therapy with or Without Orteronel

enthalten in: European urology | 2024

von Lara, P. | Mayerson, E. | Gertz, E. | +13

4

Impact of Prior Cytoreductive Nephrectomy on Efficacy in Patients with Synchronous Metastatic Renal Cell Carcinoma Treated with Avelumab plus Axitinib or Sunitinib : Post Hoc Analysis from the JAVELIN Renal 101 Phase 3 Trial

enthalten in: European urology | 2024

von Grimm, M. | Oya, M. | Choueiri, T. | +11

5

SETD2 Deficiency Confers Sensitivity to Dual Inhibition of DNA Methylation and PARP in Kidney Cancer

enthalten in: Cancer research | 2023

von Zhou, X. | Sekino, Y. | Li, H. | +12

6

Ibrutinib combination therapy for advanced gastrointestinal and genitourinary tumours : results from a phase 1b/2 study

enthalten in: BMC cancer | 2023

von Oh, D. | Maqueda, M. | Quinn, D. | +17

7

Ibrutinib combination therapy for advanced gastrointestinal and genitourinary tumours: results from a phase 1b/2 study

enthalten in: BMC cancer | 2023

von Oh, D. | Maqueda, M. | Quinn, D. | +17

8

Cell-free DNA Methylation as a Predictive Biomarker of Response to Neoadjuvant Chemotherapy for Patients with Muscle-invasive Bladder Cancer in SWOG S1314

enthalten in: European urology oncology | 2023

von Lu, Y. | Plets, M. | Morrison, G. | +13

9

Race and Treatment Outcomes in Patients With Metastatic Castration-Sensitive Prostate Cancer : A Secondary Analysis of the SWOG 1216 Phase 3 Trial

enthalten in: JAMA network open | 2023

von Sayegh, N. | Swami, U. | Jo, Y. | +9

10

Combination Treatment with Sipuleucel-T and Abiraterone Acetate or Enzalutamide for Metastatic Castration-Resistant Prostate Cancer : STAMP and STRIDE Trials

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2023

von Antonarakis, E. | Subudhi, S. | Pieczonka, C. | +8

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[36]